Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 46
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
3.
Pan Afr Med J ; 30: 149, 2018.
Artículo en Francés | MEDLINE | ID: mdl-30374395

RESUMEN

Self-induced dermatoses are more and more frequent in adolescent substance abusers with adaptation problems. We here report a case of self-induced bullous lesions on the shoulder in an adolescent with major depression and suicidal ideations. The study involved a 22-year old man, who was a chronic smoker, an occasional user of cannabis and alchool with no particular past medical history, with divorced parents, in conflict with his father. He presented with bullous eruption on the left shoulder made of bubbles, post-bullous skin erosions and scabs on a healthy skin. The monomorphic appearance of lesions, their accessibility (on the left shoulder in a right-handed patient), patient's history and his psychiatric problems have immediately suggested the investigation of self-induced dermatosis or factitious disorder. The patient admitted that he had taken psychotropic drugs and that the self-induced lesions had been caused by cigarette burns. This first psichologic evaluation also showed that the patient had suicidal ideations and a self-and hetero-aggressive behavior. The patient was treated with emollients and healing creams and referred to the Department of Psychiatry for complementary therapies.


Asunto(s)
Trastornos Fingidos/diagnóstico , Conducta Autodestructiva/diagnóstico , Enfermedades Cutáneas Vesiculoampollosas/etiología , Ideación Suicida , Quemaduras/etiología , Quemaduras/psicología , Trastorno Depresivo Mayor/psicología , Trastornos Fingidos/psicología , Humanos , Masculino , Psicotrópicos/efectos adversos , Hombro/patología , Piel/lesiones , Productos de Tabaco , Adulto Joven
5.
Skinmed ; 14(5): 367-370, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27871350

RESUMEN

Pemphigus is an autoimmune blistering skin disease that is strongly associated with different environmental factors. Among these, nutritional factors are considered to trigger pemphigus; however, their role may be underestimated. Investigated more recently in conventional medicine, this causative bond between dietary factors and blistering skin diseases was mentioned by Persian scholars such as Avicenna a thousand years ago. Avicenna, a well-known Persian physician and philosopher, who could be considered a pioneer in dermatology, discussed skin diseases in a chapter in The Canon of Medicine. He accounted for some nutritional triggers for skin blisters (mentioned as "hot swellings"), such as onion, garlic, leek, pepper, and wine. His precise description of causative factors based on principles of traditional Persian medicine (TPM) is appreciable and might well lead us to find more efficient ways for the prevention and treatment of blistering skin diseases.


Asunto(s)
Alimentos/historia , Enfermedades Cutáneas Vesiculoampollosas/historia , Dieta/efectos adversos , Dieta/historia , Alimentos/efectos adversos , Historia Medieval , Humanos , Pénfigo/etiología , Pénfigo/historia , Persia , Enfermedades Cutáneas Vesiculoampollosas/etiología , Enfermedades Cutáneas Vesiculoampollosas/prevención & control
6.
Am J Clin Dermatol ; 17(6): 653-671, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27349653

RESUMEN

Subcorneal pustular dermatosis (SPD), also known as Sneddon-Wilkinson disease, is a rare, benign yet relapsing pustular dermatosis. Its incidence and prevalence have not been well studied. It characteristically presents as hypopyon pustules on the trunk and intertriginous areas of the body. SPD is similar to two other disease entities. Both SPD-type immunoglobulin (Ig)-A pemphigus and annular pustular psoriasis clinically and histologically present similarly to SPD. Immunologic studies separate SPD-type IgA pemphigus from SPD and pustular psoriasis. However, there is still an unclear designation as to whether SPD is its own entity distinct from pustular psoriasis, as the once thought characteristic histologic picture of psoriasis does not hold true for pustular psoriasis. SPD has been reported to occur in association with several neoplastic, immunologic, and inflammatory conditions. Dapsone remains the first-line treatment for SPD, although dapsone-resistant cases have been increasingly reported. Other therapies have been used singly or as adjunctive therapy with success, such as corticosteroids, immunosuppressive agents, tumor necrosis factor inhibitors, and ultraviolet light therapy. This article provides a review of the last 30 years of available literature, with a focus on successful treatment options and a suggestion for reappraisal of the classification of SPD.


Asunto(s)
Dapsona/uso terapéutico , Pénfigo/diagnóstico , Psoriasis/diagnóstico , Enfermedades Raras , Enfermedades Cutáneas Vesiculoampollosas , Enfermedades del Tejido Conjuntivo/complicaciones , Diagnóstico Diferencial , Glucocorticoides/uso terapéutico , Enfermedades Hematológicas/complicaciones , Humanos , Inmunosupresores/uso terapéutico , Fototerapia , Enfermedades Raras/diagnóstico , Enfermedades Raras/tratamiento farmacológico , Enfermedades Raras/etiología , Recurrencia , Enfermedades Cutáneas Vesiculoampollosas/diagnóstico , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/etiología
7.
J Dermatol ; 43(8): 919-27, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26875627

RESUMEN

Eosinophilic pustular folliculitis (EPF) is a non-infectious inflammatory dermatosis of unknown etiology that principally affects the hair follicles. There are three variants of EPF: (i) classic EPF; (ii) immunosuppression-associated EPF, which is subdivided into HIV-associated (IS/HIV) and non-HIV-associated (IS/non-HIV); and (iii) infancy-associated EPF. Oral indomethacin is efficacious, especially for classic EPF. No comprehensive information on the efficacies of other medical management regimens is currently available. In this study, we surveyed regimens for EPF that were described in articles published between 1965 and 2013. In total, there were 1171 regimens; 874, 137, 45 and 115 of which were applied to classic, IS/HIV, IS/non-HIV and infancy-associated EPF, respectively. Classic EPF was preferentially treated with oral indomethacin with efficacy of 84% whereas topical steroids were preferred for IS/HIV, IS/non-HIV and infancy-associated EPF with efficacy of 47%, 73% and 82%, respectively. Other regimens such as oral Sairei-to (a Chinese-Japanese herbal medicine), diaminodiphenyl sulfone, cyclosporin and topical tacrolimus were effective for indomethacin-resistant cases. Although the preclusion of direct comparison among cases was one limitation, this study provides a dataset that is applicable to the construction of therapeutic algorithms for EPF.


Asunto(s)
Eosinofilia/tratamiento farmacológico , Foliculitis/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico , Adulto , Antibacterianos/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Medicamentos Herbarios Chinos/uso terapéutico , Eosinofilia/clasificación , Eosinofilia/etiología , Foliculitis/clasificación , Foliculitis/etiología , Infecciones por VIH/complicaciones , Humanos , Terapia de Inmunosupresión/efectos adversos , Indometacina/uso terapéutico , Lactante , Fitoterapia , Remisión Espontánea , Enfermedades Cutáneas Vesiculoampollosas/clasificación , Enfermedades Cutáneas Vesiculoampollosas/etiología , Esteroides/uso terapéutico , Resultado del Tratamiento
8.
Conn Med ; 79(2): 77-80, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26244204

RESUMEN

Presented are two cases of subcorneal pustular dermatosis (SPD), one of which was initially confused with, and treated as, a fungal infection. Eventually both cases were successfully treated with dapsone. The exact etiology and pathophysiology of SPD remains unclear and so does its classification. Dapsone remains the treatment of choice but other valid therapeutic alternatives i.e., retinoids, phototherapy, or anti-TNF inhibitors also need to be explored because of the side effects associated with dapsone.


Asunto(s)
Enfermedades Cutáneas Vesiculoampollosas/diagnóstico , Antiinfecciosos/uso terapéutico , Dapsona/uso terapéutico , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/etiología
10.
G Ital Dermatol Venereol ; 150(3): 327-9, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25946676

RESUMEN

Pseudoporphyria refers to a rare bullous dermatosis characterized by the clinical and histological features of porfiria cutanea tarda without abnormalities in porphyrin metabolism. The pathogenesis is heterogeneous and several exogenous factors may promote the bullous lesion formation, including medications, end stage renal disease, dialysis and tanning beds. Regarding treatment of this condition, in literature different therapy have been reported, such as glutathione and his precursor N-acetylcysteine, which presents anti-oxidant properties; however even more toxic drugs, such as chloroquine, are used. Moreover, in patients with drug-induced PP discontinuation of the offending agent, if possible, is a crucial aspect of the clinical management. We report two cases of dialysis patients presenting blisters on extremities, which healed with the avoidance of UV exposure and oral Vitamin D supplementation. Interestingly Vitamin D despite the lack of antioxidant properties led to a completely resolution of PP in both our patients within 30 days. A possible explanation of this finding is that Vitamin D, playing a key role in the regulation of serum Ca2+, can modulated cadherin-cadherin interactions and led to healing of pseudoporphyria bullous lesions. Finally we highlight the prominent role of UV-exposure in PP elicitation thus a good photoprotection is essential for all patients with pseudoporphyria.


Asunto(s)
Trastornos por Fotosensibilidad/tratamiento farmacológico , Diálisis Renal/efectos adversos , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico , Luz Solar/efectos adversos , Rayos Ultravioleta/efectos adversos , Deficiencia de Vitamina D/complicaciones , Vitamina D/uso terapéutico , Anciano , Calcio/fisiología , Técnicas Cosméticas/efectos adversos , Cadherinas Desmosómicas/fisiología , Diagnóstico Diferencial , Femenino , Humanos , Uniones Intercelulares , Fallo Renal Crónico/complicaciones , Fallo Renal Crónico/terapia , Persona de Mediana Edad , Nefroesclerosis/complicaciones , Diálisis Peritoneal/efectos adversos , Trastornos por Fotosensibilidad/diagnóstico , Trastornos por Fotosensibilidad/etiología , Porfiria Cutánea Tardía/diagnóstico , Porfirinas/análisis , Enfermedades Cutáneas Vesiculoampollosas/diagnóstico , Enfermedades Cutáneas Vesiculoampollosas/etiología , Vitamina D/fisiología , Deficiencia de Vitamina D/tratamiento farmacológico
12.
J Dermatolog Treat ; 25(6): 467-9, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24188033

RESUMEN

In addition to being used especially in a systematic way, herbal treatments are preferred topically by the elderly population in some rheumatological and dermatological diseases. Although alternative medicine treatments may have beneficial effects, certain plants are known to cause common contact dermatitis. Protoanemonin and sesquiterpene lactones, which are found in such plant types as respectively Ranunculus and Anthemis, often cause contact dermatitis. In this article, three cases of phyto contact dermatitis, which are the result of topical use of plant types of Ranunculus ve Anthemis as an alternative method of treatment due to myalgia or arthralgia, have been presented.


Asunto(s)
Anthemis/efectos adversos , Dermatitis por Contacto/etiología , Úlcera de la Pierna/etiología , Fitoterapia/efectos adversos , Ranunculus/efectos adversos , Enfermedades Cutáneas Vesiculoampollosas/etiología , Adulto , Anciano , Artralgia/tratamiento farmacológico , Dermatitis por Contacto/terapia , Femenino , Humanos , Úlcera de la Pierna/terapia , Masculino , Persona de Mediana Edad , Mialgia/tratamiento farmacológico , Componentes Aéreos de las Plantas/efectos adversos , Enfermedades Cutáneas Vesiculoampollosas/terapia
13.
Clin Dermatol ; 31(6): 677-700, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24160272

RESUMEN

Many dermatologic diseases are chronic with no definitive cure. For some diseases, the etiology is not completely understood, with treatment being difficult and associated with side effects. In such cases, patients may try alternative treatments to prevent onset, reduce symptom severity, or prevent reoccurrence of a disease. Dietary modification, through supplementation and exclusion, is an extremely popular treatment modality for patients with dermatologic conditions. It is, therefore, important for dermatologists to be aware of the growing body of literature pertaining to nutrition and skin disease to appropriately inform patients on benefits and harms of specific dietary interventions. We address the role of nutrition in psoriasis, atopic dermatitis, urticaria, and bullous diseases and specific dietary modifications as an adjunct or alternative to conventional therapy.


Asunto(s)
Dieta , Suplementos Dietéticos , Enfermedades de la Piel/dietoterapia , Enfermedades de la Piel/tratamiento farmacológico , Oligoelementos/uso terapéutico , Vitaminas/uso terapéutico , Acrodermatitis/tratamiento farmacológico , Acrodermatitis/etiología , Dermatitis Atópica/dietoterapia , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/etiología , Hipersensibilidad a los Alimentos/complicaciones , Humanos , Eritema Necrolítico Migratorio/etiología , Pelagra/tratamiento farmacológico , Porfirias Hepáticas/dietoterapia , Porfirias Hepáticas/tratamiento farmacológico , Porfirias Hepáticas/etiología , Psoriasis/dietoterapia , Psoriasis/tratamiento farmacológico , Psoriasis/etiología , Enfermedades de la Piel/etiología , Enfermedades Cutáneas Vesiculoampollosas/dietoterapia , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/etiología , Urticaria/dietoterapia , Urticaria/tratamiento farmacológico , Urticaria/etiología , Zinc/deficiencia
15.
Dermatol Ther ; 26(2): 173-5, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23551375

RESUMEN

Pruritic papular eruption (PPE) is a skin disease characterized by the eruption of itching papules on the extremities, face, and trunk; it is quite frequent in HIV-positive patients especially during the advanced immunosuppressive stage. PPE usually improves or heals when antiretroviral therapy restores the immune system function, but in some cases, it can take several months, and a symptomatic treatment for PPE is required. Systemic antihistamines, topical steroids, topical tacrolimus, itraconazole, pentoxyphilline, and ultraviolet B phototherapy have been proposed in cases of persisting PPE, but an elective treatment has not yet been found. We describe the case of a black patient affected by PPE, nonimproving with antiretroviral treatment, and resistant to topical steroids and oral antihistamines; a satisfactory and speedy result was achieved with narrow-band ultraviolet B phototherapy.


Asunto(s)
Infecciones por VIH/complicaciones , Prurito/radioterapia , Enfermedades Cutáneas Vesiculoampollosas/radioterapia , Terapia Ultravioleta/métodos , Adulto , Femenino , Humanos , Prurito/etiología , Enfermedades Cutáneas Vesiculoampollosas/etiología , Enfermedades Cutáneas Vesiculoampollosas/patología , Resultado del Tratamiento
16.
Clin Dermatol ; 28(6): 627-43, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21034987

RESUMEN

Autoimmune and nonautoimmune bullous diseases can both be associated with significant morbidity and mortality. Although our understanding of the pathogenic mechanisms of these diseases has increased tremendously, there is still much to learn about the various factors affecting their onset, course, and therapy. In recent years, increasing information has been published about the effect of vitamins, minerals, and other nutrients on bullous skin diseases. Some factors are believed to be inducers (thiol and phenol-containing foods in pemphigus), whereas others are believed to be protective (antioxidants in cutaneous porphyrias). This contribution reviews the evidence in the literature of the role of various dietary factors in bullous diseases, including the nonautoimmune and the deficiency dermatoses. Additional studies and new investigations are needed to provide a better understanding of the specific associations of dietary factors with bullous diseases and better management for patients affected by these conditions.


Asunto(s)
Dieta , Suplementos Dietéticos , Enfermedades Cutáneas Vesiculoampollosas/dietoterapia , Enfermedades Cutáneas Vesiculoampollosas/etiología , Acrodermatitis/dietoterapia , Acrodermatitis/etiología , Dermatitis Herpetiforme/dietoterapia , Dermatitis Herpetiforme/etiología , Dieta/efectos adversos , Dieta Sin Gluten , Epidermólisis Ampollosa/dietoterapia , Epidermólisis Ampollosa/etiología , Humanos , Eritema Necrolítico Migratorio/dietoterapia , Eritema Necrolítico Migratorio/etiología , Pelagra/dietoterapia , Pelagra/etiología , Penfigoide Ampolloso/dietoterapia , Penfigoide Ampolloso/etiología , Protoporfiria Eritropoyética/dietoterapia , Protoporfiria Eritropoyética/etiología , Zinc/deficiencia
17.
Am J Clin Dermatol ; 10(5): 301-12, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19658442

RESUMEN

Sweet syndrome, pyoderma gangrenosum, and subcorneal pustular dermatosis are neutrophilic dermatoses - conditions that have an inflammatory infiltrate consisting of mature polymorphonuclear leukocytes. The neutrophils are usually located within the dermis in Sweet syndrome and pyoderma gangrenosum; however, in subcorneal pustular dermatosis, they are found in the upper layers of the epidermis. Sweet syndrome, also referred to as acute febrile neutrophilic dermatosis, is characterized by pyrexia, elevated neutrophil count, painful erythematous cutaneous lesions that have an infiltrate of mature neutrophils typically located in the upper dermis, and prompt clinical improvement following the initiation of systemic corticosteroid therapy. Classical, malignancy-associated, and drug-induced variants of Sweet syndrome exist. Pyoderma gangrenosum is characterized by painful, enlarging necrotic ulcers with bluish undermined borders surrounded by advancing zones of erythema; its clinical variants include: ulcerative or classic, pustular, bullous or atypical, vegetative, peristomal, and drug-induced. Subcorneal pustular dermatosis is an uncommon relapsing symmetric pustular eruption that involves flexural and intertriginous areas; it can be idiopathic or associated with cancer, infections, medications, and systemic diseases. Since Sweet syndrome, pyoderma gangrenosum, and subcorneal pustular dermatosis share not only the same inflammatory cell but also similar associated systemic diseases, it is not surprising that the concurrent or sequential development of these neutrophilic dermatoses has been observed in the same individual. Also, it is not unexpected that several of the effective therapeutic interventions - including systemic drugs, topical agents, and other treatment modalities - for the management of these dermatoses are the same. The treatment of choice for Sweet syndrome and idiopathic pyoderma gangrenosum is systemic corticosteroids; however, for subcorneal pustular dermatosis, dapsone is the drug of choice. Yet, tumor necrosis factor-alpha antagonists are becoming the preferred choice when pyoderma gangrenosum is accompanied by inflammatory bowel disease or rheumatoid arthritis. Potassium iodide and colchicine are alternative first-line therapies for Sweet syndrome and indomethacin (indometacin), clofazimine, cyclosporine (ciclosporin), and dapsone are second-line treatments. Cyclosporine is effective in the acute management of pyoderma gangrenosum; however, when tapering the drug, additional systemic agents are necessary for maintaining the clinical response. In some patients with subcorneal pustular dermatosis, systemic corticosteroids may be effective; yet, systemic retinoids (such as etretinate and acitretin) have effectively been used for treating this neutrophilic dermatosis - either as monotherapy or in combination with dapsone or as a component of phototherapy with psoralen and UVA radiation. Topical agents can have an adjuvant role in the management of these neutrophilic dermatoses; however, high-potency topical corticosteroids may successfully treat localized manifestations of Sweet syndrome, pyoderma gangrenosum, and subcorneal pustular dermatosis. Intralesional corticosteroid therapy for patients with Sweet syndrome and pyoderma gangrenosum, hyperbaric oxygen and plasmapheresis for patients with pyoderma grangrenosum, and phototherapy for patients with subcorneal pustular dermatosis are other modalities that have been used effectively for treating individuals with these neutrophilic dermatoses.


Asunto(s)
Piodermia Gangrenosa/terapia , Enfermedades Cutáneas Vesiculoampollosas/terapia , Síndrome de Sweet/tratamiento farmacológico , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Humanos , Neutrófilos/metabolismo , Piodermia Gangrenosa/etiología , Piodermia Gangrenosa/fisiopatología , Enfermedades Cutáneas Vesiculoampollosas/etiología , Enfermedades Cutáneas Vesiculoampollosas/fisiopatología , Síndrome de Sweet/etiología , Síndrome de Sweet/fisiopatología
18.
Dermatology ; 219(1): 71-2, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19339769

RESUMEN

Erosive pustular dermatosis of the scalp (EPDS) is a rare, chronic inflammatory dermatosis that mostly affects elderly patients, who develop erosions, pustulation, crusting and scarring on the scalp. Its aetiology remains elusive, although the role of local trauma is being emphasized. Treatment is difficult, with several topical and systemic agents being reported to induce improvement. A 63-year-old Caucasian male had been suffering from persistent painful pustules, erosions and crusts on his scalp for 2 years. The onset of the lesions followed a CO2 laser vaporization procedure to treat multiple actinic keratoses. Different topical and systemic treatments had unsuccessfully been tried. A 4-month course of bid 0.1% tacrolimus ointment, along with strict external photoprotection, resulted in dramatic improvement, sustained after careful tapering of tacrolimus. This case is interesting in that the scalp eruption followed CO2 laser treatment. Other cases have been associated with cryosurgery, radiotherapy, surgery, and 5-FU. In fact, to our knowledge, ours is the fourth reported case of EPDS following CO2 laser treatment. Our case also strengthens previous observations as to the efficacy and safety of topical calcineurin inhibitors in this dermatosis. This is noteworthy bearing in mind the atrophic character of the skin in EPDS, which limits the usefulness of chronically administered topical steroids.


Asunto(s)
Queratosis Actínica/radioterapia , Láseres de Gas/efectos adversos , Terapia por Luz de Baja Intensidad/efectos adversos , Dermatosis del Cuero Cabelludo/etiología , Dermatosis del Cuero Cabelludo/radioterapia , Enfermedades Cutáneas Vesiculoampollosas/etiología , Enfermedad Crónica , Humanos , Masculino , Persona de Mediana Edad , Dermatosis del Cuero Cabelludo/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico
19.
Actas Dermosifiliogr ; 99(10): 803-7, 2008 Dec.
Artículo en Español | MEDLINE | ID: mdl-19091220

RESUMEN

Graft-vs-host disease is still the leading cause of morbidity and mortality in patients undergoing bone marrow transplantation. It is important to start treatment early to reduce the severity and consequences of this complication. Cutaneous lesions are often the presenting compliant of graft-vs-host disease and presage visceral involvement. We present the case of a 45-year-old woman with multiple myeloma who underwent autologous and subsequently allogeneic bone marrow transplantation with hematopoietic precursors. She developed bullous lesions with fluid elimination on the abdomen and legs. Biopsy findings were compatible with graft-vs-host disease and immunosuppressive therapy was increased. She subsequently presented oral lichenoid lesions and sicca syndrome. The bullous lesions progressed to painful ulcers that healed leaving highly sclerodermatous skin with substantial hyperpigmentation. Bullous lesions are a rare form of presentation of chronic graft-vs-host disease. In such cases, the diagnosis may not be suspected initially, particularly when the lesions are isolated and internal organs are not involved.


Asunto(s)
Enfermedad Injerto contra Huésped/diagnóstico , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Enfermedades Cutáneas Vesiculoampollosas/etiología , Biopsia , Enfermedad Crónica , Terapia Combinada , Femenino , Enfermedad Injerto contra Huésped/complicaciones , Humanos , Inmunosupresores/uso terapéutico , Liquen Plano Oral/etiología , Melanosis/etiología , Persona de Mediana Edad , Mieloma Múltiple/complicaciones , Mieloma Múltiple/tratamiento farmacológico , Mieloma Múltiple/radioterapia , Mieloma Múltiple/cirugía , Terapia PUVA , Reoperación , Síndrome de Sjögren/etiología , Piel/patología , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico , Úlcera Cutánea/etiología , Trasplante Autólogo , Trasplante Homólogo/efectos adversos
20.
Australas J Dermatol ; 49(2): 91-3, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18412808

RESUMEN

A 29-year-old woman with a 4-week history of systemic lupus erythematosus presented acutely with a severe generalized tense vesicular and bullous eruption with involvement of mucosal surfaces. At the time of her initial diagnosis of systemic lupus erythematosus, she had declined treatment, preferring to explore complementary medical therapies. Skin biopsy showed subepidermal blister formation with inflammation at the dermoepidermal junction. Direct immunofluorescence revealed strongly positive linear deposition of IgG and IgM, and positive linear granular deposition of IgA along the basement membrane zone. Electron microscopy showed that the level of the basement membrane split was below the lamina densa. A diagnosis of bullous systemic lupus erythematosus was made and dapsone was commenced, with a dramatic improvement in her skin eruption. The patient again declined further treatment of her systemic disease and sought complementary therapies, and subsequently presented with cerebral involvement.


Asunto(s)
Dapsona/uso terapéutico , Inmunosupresores/uso terapéutico , Lupus Eritematoso Sistémico/complicaciones , Enfermedades Cutáneas Vesiculoampollosas/etiología , Piel/patología , Adulto , Anticuerpos Antinucleares/análisis , Terapias Complementarias , Femenino , Humanos , Lupus Eritematoso Sistémico/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/patología , Negativa del Paciente al Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA